PHILADELPHIA, Nov. 30 /PRNewswire-FirstCall/ -- On Monday, December 4, 2006, GlaxoSmithKline will hold an "Avandia In Focus" webcast and teleconference for analysts and investors, which you are invited to attend. David Stout, President, Pharmaceutical Operations, together with senior representatives from R&D and US Pharmaceutical Operations will present on GSK's Avandia portfolio, followed by a Q&A session.
Meeting Time: Date: Monday, December 4, 2006 Time: 11:00am - 12:30pm EST Webcast Details:
The audio and slide webcast will be available from the GSK homepage at http://www.gsk.com from 10:30am EST on December 4th. Registration will be available starting November 29, 2006.
The on-demand version of the webcast will be available on http://www.gsk.com December 5th at 5:00pm EST.
Teleconference Details: To participate in the teleconference please dial one of the numbers below. US Toll Free 1 866 213 5928 International Dial in Number + 44 (0) 1452 560 841 Chairperson "David Stout" A recording of the teleconference will be available from 1:30pm EST on December 4th and will run until December 18th. US Toll Free 1 866 247 4222 International Dial in Number +44 (0) 1452 55 00 00 Passcode: 3002730#
GlaxoSmithKlineCONTACT: US Media inquiries: Nancy Pekarek, +1-215-751-7709, or Mary AnneRhyne, +1-919-483-2839, or Patty Seif, +1-215-751-7709, or Gaile Renegar,+1-215-483-2839, or US Analyst/ Investor inquiries: Frank Murdolo,+1-215-751- 7002, or Tom Curry, +1-215-751-5419, all of GlaxoSmithKline plc
Web site: http://www.gsk.com/
Company News On-Call: http://www.prnewswire.com/comp/801350.html/
